Work

A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer

Year: 2004

Type: article

Study design: Clinical Trial

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2004.08.009

Authors: Heidi H. Gillenwater, Thomas E. Stinchcombe, Bahjat F. Qaqish, Maureen Tyann, Thomas A. Hensing, Mark A. Socinski

Institutions: University of Virginia Health System, University of Virginia, University of North Carolina at Chapel Hill, Evanston Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, University of Virginia

OpenAlex ID: W2153000304

FWCI: 0.828

Cites: 20

Cited by: 8

Related to: 10